Atea Pharmaceuticals (AVIR) Amortizatization of Intangibles (2022 - 2026)

Atea Pharmaceuticals' Amortizatization of Intangibles history spans 5 years, with the latest figure at $581000.0 for Q1 2026.

  • Quarterly Amortizatization of Intangibles fell 66.61% to $581000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Mar 2026, down 62.42% year-over-year, with the annual reading at $4.9 million for FY2025, 58.18% down from the prior year.
  • Amortizatization of Intangibles came in at $581000.0 for Q1 2026, down from $808000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $7.9 million in Q4 2022 to a low of $581000.0 in Q1 2026.
  • The 5-year median for Amortizatization of Intangibles is $2.9 million (2024), against an average of $2.9 million.
  • Year-over-year, Amortizatization of Intangibles grew 12.99% in 2024 and then tumbled 70.22% in 2025.
  • Atea Pharmaceuticals' Amortizatization of Intangibles stood at $7.9 million in 2022, then tumbled by 45.21% to $4.3 million in 2023, then plummeted by 37.56% to $2.7 million in 2024, then crashed by 70.22% to $808000.0 in 2025, then dropped by 28.09% to $581000.0 in 2026.
  • Per Business Quant, the three most recent readings for AVIR's Amortizatization of Intangibles are $581000.0 (Q1 2026), $808000.0 (Q4 2025), and $1.1 million (Q3 2025).